Clarithromycin and Linagliptin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clarithromycin (clarithromycin) and Linagliptin (linagliptin). Common drug interactions include fall among females and hypotension among males.

The phase IV clinical study analyzes what interactions people have when they take Clarithromycin and Linagliptin. It is created by eHealthMe based on reports of 96 people who take the same drugs from the FDA, and is updated regularly.

What is Clarithromycin?

Clarithromycin has active ingredients of clarithromycin. It is often used in sinusitis. eHealthMe is studying from 45,044 Clarithromycin users. Check the latest studies of Clarithromycin.

What is Linagliptin?

Linagliptin has active ingredients of linagliptin. eHealthMe is studying from 8,112 Linagliptin users. Check the latest studies of Linagliptin.



On Jul, 10, 2026

96 people who take Clarithromycin and Linagliptin together, and have interactions are studied.

Clarithromycin and Linagliptin drug interactions.

What are the common drug interactions of Clarithromycin and Linagliptin, by gender? *:

female:

  1. Fall
  2. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  3. Mobility decreased (ability to move is reduced)
  4. Organising pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue)
  5. Pain in extremity
  6. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  7. Cardiac failure acute
  8. Drug ineffective
  9. Electrocardiogram qt prolonged
  10. Erythema (redness of the skin)

male:

  1. Hypotension (abnormally low blood pressure)
  2. Pyrexia (fever)
  3. Petit mal epilepsy (absence seizure)
  4. Cardioactive drug level increased
  5. Rash macular (small, flat red spots)
  6. Brain natriuretic peptide increased
  7. Device occlusion
  8. Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
  9. Frequent bowel movements
  10. Hydronephrosis (water inside the kidney)

What are the common drug interactions of Clarithromycin and Linagliptin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Hallucination, visual (seeing things that aren't there)

50-59:

  1. Diffuse panbronchiolitis (inflammatory lung disease)
  2. Lethargy (tiredness)
  3. Pathological fracture (broken bone caused by disease)

60+:

  1. Hypotension (abnormally low blood pressure)
  2. Pyrexia (fever)
  3. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  4. Dehydration (dryness resulting from the removal of water)
  5. Electrocardiogram qt prolonged
  6. Erythema (redness of the skin)
  7. Flushing (the warm, red condition of human skin)
  8. Hyperkalaemia (damage to or disease of the kidney)
  9. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  10. Lung neoplasm malignant (cancer tumour of lung)

What are the existing conditions these people have? *

  1. Diabetes: 10 people, 10.42%
  2. Ill-Defined Disorder: 9 people, 9.38%
  3. Diabetic Foot: 8 people, 8.33%
  4. High Blood Pressure: 7 people, 7.29%
  5. High Blood Cholesterol: 7 people, 7.29%
  6. Constipation: 7 people, 7.29%
  7. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 6 people, 6.25%
  8. Dyslipidaemia (abnormal amount of lipids): 6 people, 6.25%
  9. Type 2 Diabetes: 5 people, 5.21%
  10. Psoriasis (immune-mediated disease that affects the skin): 5 people, 5.21%

* Approximation only. Some reports may have incomplete information.

Do you take Clarithromycin and Linagliptin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Clarithromycin and Linagliptin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clarithromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Linagliptin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clarithromycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Linagliptin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on clarithromycin and linagliptin (the active ingredients of Clarithromycin and Linagliptin, respectively), and Clarithromycin and Linagliptin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: